Skip to main content

Preclinical studies on a recombinant Group B meningococcal porin as a carrier for a novel Haemophilus influenzae Type b conjugate vaccine.

Fusco P., Michon F., Laude-Sharp M., Minetty C.A.S.A., Huang C., Heron I., and Blake M. Preclinical studies on a recombinant Group B meningococcal porin as a carrier for a novel Haemophilus influenzae Type b conjugate vaccine. Vaccine. 1998, Vol 16, 1842-1849.

Page updated January 28, 2025 | published January 1, 1998

Subscribe to NIMHD Email

 

Choose the topics right for you to get details on NIMHD research, funding opportunities, programs, training, events, resources and news directly to your inbox.